Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 11:11:1415877.
doi: 10.3389/fmed.2024.1415877. eCollection 2024.

Determinants of anemia among patients receiving cancer chemotherapy in Northwest Ethiopia

Samuel Agegnew Wondm  1 , Samuel Berihun Dagnew  2 , Kale Gubae  3 , Tegenu Chanie Tesfaye  1 , Fasil Bayafers Tamene  1
Affiliations

Determinants of anemia among patients receiving cancer chemotherapy in Northwest Ethiopia

Samuel Agegnew Wondm et al. Front Med (Lausanne). .

Abstract

Background: Chemotherapy-induced anemia (CIA) is a hematologic complication that frequently affects patients with cancer undergoing chemotherapy. It is associated with worse treatment outcomes, higher rates of morbidity and mortality, worse quality of life, and higher healthcare costs. The incidence and predictors of CIA in Ethiopia, particularly in Northwest Ethiopian oncology centers, are poorly understood. This study was conducted at Northwest Ethiopian oncology centers to evaluate the incidence and determinants of chemotherapy-induced anemia in adult patients with cancer undergoing chemotherapy.

Methods: This 3-year hospital-based retrospective follow-up study included adult patients with cancer receiving chemotherapy between 2019 and 2021 at two oncology centers in Northwest Ethiopia. Data were collected from October to December 2021. A binary logistic regression model was used to select variables and determine the Crude Odds Ratio (COR). Variables with P-value < 0.2 were entered into the multivariable logistic regression and Adjusted odds ratio (AOR) with 95% Confidence intervals (CI) for variables with P-value < 0.05 were estimated to show determinants of chemotherapy-induced anemia among cancer patients who received chemotherapy.

Results: A total of 402 patients were included in the final analysis. The overall incidence of CIA was 75.4% (95% CI 70.7, 79.8). Older age [AOR = 1.8, 95% CI (1.4-3.5); P = 0.043], hematologic cancer [AOR = 3.7, 95% CI (3.2-5.7), P = 0.021], obesity [AOR = 3.4, 95% CI (2.3-6.9); P = 0.028], ≥6 chemotherapy cycles [AOR = 3.8, 95% CI (3.2-5.1), P = 0.019], cancer metastasis to bone [AOR = 2.9, 95% CI (1.2-4.7), P = 0.025] were statistically significant predictors of chemotherapy-induced anemia.

Conclusion: Chemotherapy-induced anemia persisted in a significant percentage of cancer patients. Chemotherapy-induced anemia developed in three-quarters of patients undergoing chemotherapy. Chemotherapy-induced anemia was significantly associated with older age, hematologic malignancy, obesity, a greater number of chemotherapy cycles, and cancer metastasis to bone. To lower the risk of morbidity related to anemia, patients with chemotherapy-induced anemia should be regularly evaluated and treated with appropriate treatment.

Keywords: Northwest Ethiopia; anemia; cancer; chemotherapy; determinants; incidence.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Study population inclusion and exclusion flow diagram.
Figure 2
Figure 2
The Overall incidence of chemotherapy-induced amenia among patients with cancer receiving chemotherapy (n = 402).
Figure 3
Figure 3
Severity of anemia among patients with cancer receiving chemotherapy (n = 303).
Figure 4
Figure 4
Morphological classification of chemotherapy-induced anemia among cancer patients receiving chemotherapy (n = 303).
See this image and copyright information in PMC

References

    1. Kifle E, Hussein M, Alemu J, Tigeneh W. Prevalence of anemia and associated factors among newly diagnosed patients with solid malignancy at Tikur Anbessa Specialized Hospital, Radiotherapy Center, Addis Ababa, Ethiopia. Adv Hematol. (2019) 2019:8279789. 10.1155/2019/8279789 - DOI - PMC - PubMed
    1. Neoh K, Stanworth S, Pasricha SR, Bennett MI. Estimating prevalence of functional iron deficiency anemia in advanced cancer. Support Care Cancer. (2017) 25:1209–14. 10.1007/s00520-016-3511-9 - DOI - PubMed
    1. Xu H, Xu L, Page JH, Cannavale K, Sattayapiwat O, Rodriguez R, et al. Incidence of anemia in patients diagnosed with solid tumors receiving chemotherapy, 2010-2013. Clin Epidemiol. (2016) 8:61–71. 10.2147/CLEP.S89480 - DOI - PMC - PubMed
    1. Hassan BA, Yusoff ZB. Treatment patterns and outcomes in the management of solid cancer patients suffering from anemia in Penang Hospital. Asian Pac J Cancer Prev. (2011) 12:1573–6. - PubMed
    1. Aapro M, Österborg A, Gascón P, Ludwig H, Beguin Y. Prevalence and management of cancer-related anemia, iron deficiency and the specific role of IV iron. Ann Oncol. (2012) 23:1954–62. 10.1093/annonc/mds112 - DOI - PubMed

LinkOut - more resources